Clinical trial
Nitric Oxide to Treat Pulmonary Embolism
NCT01939301 · Indiana University School of Medicine, Other · Completed
Key facts
| NCT number | NCT01939301 |
|---|---|
| Title | Nitric Oxide to Treat Pulmonary Embolism |
| Official title | Randomized Trial of Inhaled Nitric Oxide to Treat Acute Pulmonary Embolism |
| Lead sponsor | Indiana University School of Medicine, Other |
| Collaborators | Mallinckrodt Industry National Institutes of Health (NIH) NIH University of Mississippi Medical Center University of Texas, Southwestern Medical Center at Dallas National Heart, Lung, and Blood… |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pulmonary Embolism |
| Intervention type | Drug |
| Interventions | Inhaled Nitric Oxide, Sham |
| Enrollment | 78 |
| Start date | Oct 1, 2013 |
| Primary completion | Oct 31, 2016 |
| Completion | Oct 31, 2016 |
| First posted | Sep 11, 2013 |
| Last update posted | Oct 3, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: